Cancer patients’ perspectives on participating in a community pharmacy-based hyperglycaemia screening service – A qualitative exploration of enablers and barriers

Abstract

Background: Patients diagnosed with cancer are often treated with high dose glucocorticosteroids, increasing their risk of developing hyperglycaemia or steroid-induced diabetes, which can be reduced by regular monitoring of blood glucose levels. Community pharmacies can provide easily accessible monitoring services to patients, but may not be convenient or acceptable for people with a cancer diagnosis. Objectives: To explore patients’ motivations, perceptions of benefits and barriers influencing their decisions to participate in a novel community pharmacy-based hyperglycaemia screening and monitoring program. Methods: Patients initiated on high-dose-glucocorticosteroids at a quaternary cance..